Clearly boardsters are disappointed because there’s no item on the agenda about the NGIO uplist. But..there was never any guarantee on Joe’s part that uplist would be discussed on the 2/5 call. We just assumed that to be the case. Friday’s apparent focus is covid vaccine development and covid treatments, with amplification on the various China deals. I say deals only because it’s unclear to me for which of several deals the $1m was paid. I’m not sure that it was a substitute for the $5m payment or simply a payment in another deal. But that I’m sure will be asked on Friday. I’m pleased to get ANY reliable good news at this point.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links